Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.275 USD | +17.41% | +68.01% | +8.42% |
Jun. 07 | HC Wainwright Adjusts Price Target on Replimune to $17 From $12, Maintains Buy Rating | MT |
Jun. 06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
Financials (USD)
Sales 2025 * | - | Sales 2026 * | 21.49M | Capitalization | 485M |
---|---|---|---|---|---|
Net income 2025 * | -231M | Net income 2026 * | -231M | EV / Sales 2025 * | - |
Net cash position 2025 * | 144M | Net cash position 2026 * | 167M | EV / Sales 2026 * | 14.8 x |
P/E ratio 2025 * |
-2.34
x | P/E ratio 2026 * |
-2.92
x | Employees | 331 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 94.34% |
Latest transcript on Replimune Group, Inc.
1 day | +11.11% | ||
1 week | +49.91% | ||
Current month | +49.91% | ||
1 month | +17.38% | ||
3 months | -12.51% | ||
6 months | +8.37% | ||
Current year | -6.29% |
Managers | Title | Age | Since |
---|---|---|---|
Sushil Patel
CEO | Chief Executive Officer | 52 | 21-05-02 |
Founder | 51 | 15-02-28 | |
Robert Coffin
FOU | Founder | 58 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paolo Pucci
BRD | Director/Board Member | 63 | 20-03-31 |
Joseph Slattery
BRD | Director/Board Member | 59 | 17-09-30 |
Robert Coffin
FOU | Founder | 58 | 15-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.03% | 775 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 9.15 | +15.82% | 1 235 668 |
24-06-07 | 7.9 | +11.11% | 2,622,480 |
24-06-06 | 7.11 | +27.88% | 5,842,671 |
24-06-05 | 5.56 | +9.66% | 951,257 |
24-06-04 | 5.07 | -6.80% | 782,980 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.29% | 485M | |
+51.85% | 57.87B | |
+41.70% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- REPL Stock